# Propofol Versus Sevoflurane During FESS

> **NCT04619160** · PHASE4 · UNKNOWN · sponsor: **Algemeen Ziekenhuis Maria Middelares** · enrollment: 60 (estimated)

## Conditions studied

- Sinus Infection Chronic

## Interventions

- **DRUG:** Propofol
- **DRUG:** Sevoflurane

## Key facts

- **NCT ID:** NCT04619160
- **Lead sponsor:** Algemeen Ziekenhuis Maria Middelares
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2021-03
- **Final completion:** 2021-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04619160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04619160, "Propofol Versus Sevoflurane During FESS". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04619160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*